Company: MDCXW
Filing Date: 2025-09-29
Form Type: S-1
Source: 0001062993-25-015841
Chunk: 140

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-29
Form: S-1
Chunk 140
---
 lyophilizate obtained thereby |  17/255,372 | 7/5/2018 | 7/2/2019 | 11,719,488 | 7/19/2023  | 7/2/2039   | Issued  | Antev Limited |
| United States | A lyophilization process and a Teverelix-TFA lyophilizate obtained thereby |  18/348,722 | 7/5/2018 | 7/7/2023 |            |            | 7/2/2039   | Pending | Antev Limited |
| Canada        | A lyophilization process and a Teverelix-TFA lyophilizate obtained thereby |     3141521 | 7/5/2018 | 7/2/2019 |            |            | 7/2/2039   | Pending | Antev Limited |
| China         | A lyophilization process and a Teverelix-TFA lyophilizate obtained thereby |   112423776 | 7/5/2018 | 7/2/2019 |  112423776 | 5/31/2024  | 7/2/2039   | Issued  | Antev Limited |
| Europe        | A lyophilization process and a Teverelix-TFA lyophilizate obtained thereby |  19742691.9 | 7/5/2018 | 7/2/2019 |    3817760 | 9/7/2022   | 7/2/2039   | Issued  | Antev Limited |
| Germany       | A lyophilization process and a Teverelix-TFA lyophilizate obtained thereby |  19742691.9 | 7/5/2018 | 7/2/2019 |    3817760 | 9/7/2022   | 7/2/2039   | Issued  | Antev Limited |
| France        | A lyophilization process and a Teverelix-TFA lyophilizate obtained thereby |  19742691.9 | 7/5/2018 | 7/2/2019 |    3817760 | 9/7/2022   | 7/2/2039   | Issued  | Antev Limited |
| Great Britain |